These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 17136563

  • 1. Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
    Bovenschen HJ, Gerritsen WJ, van Rens DW, Seyger MM, de Jong EM, van de Kerkhof PC.
    Arch Dermatol Res; 2007 Feb; 298(9):457-63. PubMed ID: 17136563
    [Abstract] [Full Text] [Related]

  • 2. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ, Erceg A, Van Vlijmen-Willems I, Van De Kerkhof PC, Seyger MM.
    J Dermatolog Treat; 2007 Feb; 18(1):32-9. PubMed ID: 17365265
    [Abstract] [Full Text] [Related]

  • 3. The effect of topical corticosteroids in combination with alefacept on circulating T-cell subsets in psoriasis.
    Langewouters AM, Bovenschen HJ, De jong EM, Van Erp PE, Van De Kerkhof PC.
    J Dermatolog Treat; 2007 Feb; 18(5):279-85. PubMed ID: 17852631
    [Abstract] [Full Text] [Related]

  • 4. The effect of alefacept on T-cell subsets and cells expressing NK receptors in lesional psoriatic skin: the effects of monotherapy and combination treatment with calcipotriol.
    Vissers WH, van Duijnhoven M, van Erp PE, de Jong EM, van de Kerkhof PC.
    J Dermatolog Treat; 2008 Feb; 19(6):344-50. PubMed ID: 19016104
    [Abstract] [Full Text] [Related]

  • 5. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
    Vissers WH, Berends M, Muys L, van Erp PE, de Jong EM, van de Kerkhof PC.
    Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
    [Abstract] [Full Text] [Related]

  • 6. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
    Vissers WH, van Vlijmen I, van Erp PE, de Jong EM, van de Kerkhof PC.
    Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
    [Abstract] [Full Text] [Related]

  • 7. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study.
    Bovenschen HJ, Langewouters AM, van de Kerkhof PC.
    Am J Clin Dermatol; 2010 Apr; 11(5):343-50. PubMed ID: 20553063
    [Abstract] [Full Text] [Related]

  • 8. Changes in circulating lymphocyte subpopulations following administration of the leucocyte function-associated antigen-3 (LFA-3)/IgG1 fusion protein alefacept.
    Larsen R, Ryder LP, Svejgaard A, Gniadecki R.
    Clin Exp Immunol; 2007 Jul; 149(1):23-30. PubMed ID: 17403057
    [Abstract] [Full Text] [Related]

  • 9. Oral retinoic acid metabolism blocking agent Rambazole for plaque psoriasis: an immunohistochemical study.
    Bovenschen HJ, Otero ME, Langewouters AM, van Vlijmen-Willems IM, van Rens DW, Seyger MM, van de Kerkhof PC.
    Br J Dermatol; 2007 Feb; 156(2):263-70. PubMed ID: 17223865
    [Abstract] [Full Text] [Related]

  • 10. Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions.
    van Duijnhoven MW, Körver JE, Vissers WH, van Vlijmen-Willems IM, Pasch MC, van Erp PE, Van de Kerkhof PC.
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):27-33. PubMed ID: 16405604
    [Abstract] [Full Text] [Related]

  • 11. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ, Seyger MM, Van de Kerkhof PC.
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.
    Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE, Alefacept Clinical Study Group.
    Arch Dermatol; 2003 Jun; 139(6):719-27. PubMed ID: 12810502
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
    Bovenschen HJ, Gerritsen WJ, de Jong EM, van de Kerkhof PC.
    Acta Derm Venereol; 2006 Jun; 86(3):281-2. PubMed ID: 16710605
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Flexural versus plaque lesions in psoriasis: an immunohistochemical differentiation.
    Vissers WH, Roelofzen J, De Jong EM, Van Erp PE, Van de Kerkhof PC.
    Eur J Dermatol; 2005 Jun; 15(1):13-7. PubMed ID: 15701587
    [Abstract] [Full Text] [Related]

  • 18. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP, Van Erp PE, Van De Kerkhof PC.
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [Abstract] [Full Text] [Related]

  • 19. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH.
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.